Results 1 to 10 of about 60 (60)
Selection of an ACE inhibitor in clinical practice
Медицинский совет, 2014 Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class ...
OD Ostroumova +3 more
doaj +1 more source
Choosing antihypertensive drug for the treatment of hypertension
Медицинский совет, 2013 The article tells about modern approaches to differentiated choice of antihypertensive drugs. The advantages and limitations of five key classes of antihypertensive medications are described.
O. D. Ostroumova, I. I. Kopchyonov
doaj +1 more source
Медицинский совет, 2014 High incidence of cardiovascular diseases globally, including arterial hypertension (AH) and coronary artery disease (CAD), as well as a considerable social impact made by the diseases and their complications, call for finding new ways to improve ...
O. A. Lednev
doaj +1 more source
The role of fosinopril in the treatment and prevention of cardiovascular diseases
Медицинский совет, 2015 In Russia, cardiovascular diseases account for 57% of deaths in the overall mortality. Arterial hypertension (AH) is one of the main risk factors (RF) for cardiovascular diseases (along with dyslipidemia, smoking, metabolic syndrome, diabetes mellitus ...
G. A. Baryshnikova
doaj +1 more source
ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
Медицинский совет, 2014 Fosinopril with dual clearance can be used in renal failure without dose correction, which may be required in diabetes or elderly patients even with normal creatinine level in blood plasma.
AO Konradi
doaj +1 more source
Медицинский совет, 2013 One of the major challenges in the modern medicine is chronic heart failure (CHF) characterized by high incidence, really unfavourable prognosis and high cost of treatment.
G. N. Gorokhovskaya +2 more
doaj +1 more source
Качественная клиническая практика, 2018 Сердечно-сосудистые заболевания являются одной из основных причин смертности. Среди болезней системы кровообращения артериальная гипертония (АГ) занимает ведущее место.
doaj
Фармакокинетика и Фармакодинамика, 2014 In a single-dose, two-treatment, two-period, two-sequence crossover study with a 1-week washout period was carry out the bioequivalence study of two tablet coated formulation of fosinopril that given to 18 volunteers in equal doses (20 mg).
A. K. Sariev +7 more
doaj
Исследование сравнительной фармакокинетики и биоэквивалентности препаратов Кардиоприл и Моноприл®
Фармакокинетика и Фармакодинамика, 2012 В рамках перекрёстного, однократного, открытого, рандомизированного исследования с однонедельным периодом отмывки, с двумя последовательностями была изучена биоэквивалентность двух таблетированных форм фозиноприла на 18 добровольцах (дозировка 20 мг ...
doaj
КардиоСоматика, 2017 Актуальность. Среди различных заболеваний сердечно-сосудистой системы ишемическая болезнь сердца (ИБС) занимает «первое почетное» место. Актуальность проблемы ИБС обусловлена тем, что данное заболевание весьма широко распространено и является основной ...
Yu. I Bart, Yu. V Luneva, S. V Povetkin
doaj